UNSPSC 51391715: Dipivefrin or dipivefrine

This classification denotes an anti-glaucoma agent with the molecular formula C19H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Q1PVL543G, chemically known as 4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat but generally known as dipivefrin, which bears US NIH Compound Identifier 3105. European Medicines Agency schedules Dipivefrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07217MIG.

UNSPSC 51391715 Dipivefrin or dipivefrine is a Commodity code that covers pharmaceutical products used in ophthalmic and emergency medical applications. State and local governments procuring under this code purchase pharmaceutical supplies to support community health, emergency response, and healthcare delivery programs. The issuing bodies are primarily county health departments and community health agencies managing procurement for direct distribution to clinics, emergency services, and public health facilities.

Seminole County, Florida is the primary recent buyer identified in the market, having posted IFB60459723LAS in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation closed July 26, 2023, through the county's e-Procurement Portal, requiring vendors to include shipping and delivery costs in their proposals and to meet E-Verify compliance, drug-free workplace certification, and workers' compensation and commercial general liability insurance requirements. The contract included an initial two-year term with a one-year renewal option and carried a three-month probationary termination clause. While the source names only one recent opportunity, the specificity of the Seminole County procurement and its focus on emergency medical supplies signals active procurement interest in this pharmaceutical category among Florida county health agencies.